TP53 and familial pancreatic carcinoma: A recent study has illustrated that p53 has binding sites in the ALKBH5 promoter and can induce the activation of ALKBH5 transcription, which acts as a feedback loop to regulate the m6A modification in pancreatic cancer [35].